| 1 |
FP301 |
Outcomes of Ruthenium Plaque Brachytherapy in OSSN with Corneal Stromal and Scleral Invasion |
DR. GAURAV GARG |
DR. GAURAV GARG |
| 2 |
FP441 |
Artificial Intelligence and Machine Learning in Ocular Oncology: Retinoblastoma |
Dr. SWATHI KALIKI |
Dr. SWATHI KALIKI |
| 3 |
FP1172 |
ASSOCIATION OF P53 GENE MUTATION IN VARIOUS EYELID CARCINOMAS |
DR. SANJAY BOSAK |
DR. SANJAY BOSAK |
| 4 |
FP1237 |
Immune Profiling of Covid Associated Rhino Orbito Cerebral Mucormycosis (Ca ROCM) |
DR. GUPTA ROSHMI |
DR. GUPTA ROSHMI |
| 5 |
FP1559 |
Multimodal Management in Orbital Rhabdomyosarcoma can Optimise Eye and Life Salvage |
DR.HARIKA REGANI |
DR.HARIKA REGANI |
| 6 |
FP1583 |
Correlation of Risk Factors & Adjuvant Therapy in the Era of Secondary Enucleation in Retinoblastoma |
DR. ROLIKA BANSAL |
DR. ROLIKA BANSAL |
| 7 |
FP1761 |
To evaluate classification systems of retinoblastoma in prognosticating survival and eye salvage. |
Dr. SIMA DAS |
Dr. SIMA DAS |
| 8 |
FP1793 |
TITLE: Intra-arterial chemotherapy in refractory and advance retinoblastoma: A game changer. |
Dr. NAMITA KUMARI |
Dr. NAMITA KUMARI |
| 9 |
FP1806 |
Prognostic significance of survivin (BIRC5) in retinoblastoma |
Dr. KAUSTUBH MULAY |
Dr. KAUSTUBH MULAY |
| 10 |
FP1930 |
Ruthenium 106 episcleral brachytherapy in ocular tumours-Experience from a tertiary centre |
DR. NIMMY RAJ |
Dr. NEIWETE LOMI |